Skip to main content

Development of a Commercial-Ready Product for Cancer Screening using Liquid Biopsies

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Dec 4, 2015
Award amount: 
$250,000
Organization name: 
BioFluidica, Inc.
Principal Investigator: 
Muller, Rolf
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

BioFluidica, Inc. is developing automated instrumentation for the detection, quantitation, and characterization of circulating tumor cells (CTCs) in whole blood as a biomarker for cancer detection and treatment management. CTCs are found at extremely low concentrations in blood, which requires isolation and detection methods with high levels of recovery and purity. BioFluidica has developed a portable instrument that works in conjunction with a disposable plastic cartridge to fully automate and rapidly enumerate CTCs for the detection of metastatic cancers.

Fiscal year: 
2016